Enovis (ENOV) Competitors $34.03 -1.91 (-5.31%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$34.02 -0.02 (-0.04%) As of 07/11/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENOV vs. CG, AVNT, BC, DOV, EVR, ITT, IVZ, GKOS, IRTC, and NARIShould you be buying Enovis stock or one of its competitors? The main competitors of Enovis include Carlyle Group (CG), Avient (AVNT), Brunswick (BC), Dover (DOV), Evercore (EVR), ITT (ITT), Invesco (IVZ), Glaukos (GKOS), iRhythm Technologies (IRTC), and Inari Medical (NARI). Enovis vs. Its Competitors Carlyle Group Avient Brunswick Dover Evercore ITT Invesco Glaukos iRhythm Technologies Inari Medical Carlyle Group (NASDAQ:CG) and Enovis (NYSE:ENOV) are related companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk. Is CG or ENOV more profitable? Carlyle Group has a net margin of 19.00% compared to Enovis' net margin of -37.65%. Carlyle Group's return on equity of 23.78% beat Enovis' return on equity.Company Net Margins Return on Equity Return on Assets Carlyle Group19.00% 23.78% 6.40% Enovis -37.65%5.99%3.44% Which has more volatility and risk, CG or ENOV? Carlyle Group has a beta of 1.86, meaning that its stock price is 86% more volatile than the S&P 500. Comparatively, Enovis has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500. Which has preferable earnings & valuation, CG or ENOV? Carlyle Group has higher revenue and earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Carlyle Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarlyle Group$5.43B3.88$1.02B$2.9519.78Enovis$2.11B0.92-$825.49M-$13.95-2.44 Do analysts rate CG or ENOV? Carlyle Group currently has a consensus price target of $56.93, suggesting a potential downside of 2.43%. Enovis has a consensus price target of $55.60, suggesting a potential upside of 63.39%. Given Enovis' stronger consensus rating and higher possible upside, analysts plainly believe Enovis is more favorable than Carlyle Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carlyle Group 1 Sell rating(s) 7 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.44Enovis 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Do institutionals & insiders hold more shares of CG or ENOV? 55.9% of Carlyle Group shares are held by institutional investors. Comparatively, 98.5% of Enovis shares are held by institutional investors. 26.3% of Carlyle Group shares are held by company insiders. Comparatively, 2.7% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor CG or ENOV? In the previous week, Carlyle Group had 24 more articles in the media than Enovis. MarketBeat recorded 31 mentions for Carlyle Group and 7 mentions for Enovis. Carlyle Group's average media sentiment score of 0.79 beat Enovis' score of 0.46 indicating that Carlyle Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Carlyle Group 11 Very Positive mention(s) 3 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Enovis 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCarlyle Group beats Enovis on 13 of the 16 factors compared between the two stocks. Get Enovis News Delivered to You Automatically Sign up to receive the latest news and ratings for ENOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ENOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENOV vs. The Competition Export to ExcelMetricEnovisMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$1.94B$1.95B$5.56B$20.66BDividend YieldN/AN/A5.07%3.72%P/E Ratio-2.4434.5628.2127.82Price / Sales0.9215.80432.3842.48Price / Cash1.7754.0237.1222.32Price / Book0.758.368.044.57Net Income-$825.49M-$62.39M$3.19B$989.30M7 Day Performance1.13%5.08%3.63%0.20%1 Month Performance5.39%8.13%4.06%3.95%1 Year Performance-26.07%5.64%30.02%10.27% Enovis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENOVEnovis2.6062 of 5 stars$34.03-5.3%$55.60+63.4%-25.5%$1.94B$2.11B-2.447,367Positive NewsAnalyst ForecastCGCarlyle Group3.8117 of 5 stars$51.40+0.4%$53.00+3.1%+37.0%$18.48B$5.43B17.422,300Trending NewsAnalyst UpgradeAVNTAvient4.5177 of 5 stars$32.36-1.5%$46.80+44.6%-21.6%$3.01B$3.24B12.359,200News CoverageDividend AnnouncementGap DownBCBrunswick4.7114 of 5 stars$55.29-0.5%$70.00+26.6%-20.3%$3.65B$5.24B45.6915,000News CoverageDOVDover4.4565 of 5 stars$183.34+0.0%$208.58+13.8%+3.8%$25.13B$7.75B11.0424,000Trending NewsEVREvercore3.9358 of 5 stars$270.85+0.7%$250.57-7.5%+29.6%$10.52B$2.98B25.922,380Analyst ForecastITTITT4.4316 of 5 stars$156.93-0.6%$165.50+5.5%+19.5%$12.43B$3.63B24.9511,700News CoverageIVZInvesco4.7402 of 5 stars$15.80+0.6%$17.42+10.2%+9.1%$7.03B$6.07B12.648,500News CoverageAnalyst ForecastGKOSGlaukos4.3435 of 5 stars$103.42+2.0%$134.67+30.2%-15.9%$5.80B$383.48M0.00780IRTCiRhythm Technologies1.0422 of 5 stars$153.96-0.5%$138.60-10.0%+39.7%$4.94B$591.84M0.002,000NARIInari Medical0.2726 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800News Coverage Related Companies and Tools Related Companies Carlyle Group Competitors Avient Competitors Brunswick Competitors Dover Competitors Evercore Competitors ITT Competitors Invesco Competitors Glaukos Competitors iRhythm Technologies Competitors Inari Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ENOV) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enovis Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Enovis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENOV Stock Alerts